Paracetamol use in pregnancy runs the risk of asthma in child

A team of U.K. scientists found evidence suggesting that the risk of childhood asthma associated with prenatal paracetamol exposure may depend on antioxidant genes in the mother.

The results of the study, which strengthens the argument for a causal link between paracetamol exposure in early life and later childhood asthma, are published in the Journal of Allergy and Clinical Immunology.

The team, which is led by Seif Shaheen, Professor of Respiratory Epidemiology at Barts and The London School of Medicine and Dentistry, examined data from the British Avon Longitudinal Study of Parents and Children that has followed 14,000 children since birth - beginning with their mothers' pregnancies and continuing into the children's 8th year.

Researchers looked for evidence of interaction between paracetamol use during pregnancy or infancy and antioxidant genes in the mother or child. Variants in such genes may influence the toxicity of paracetamol.

Participating mothers reported on their use of paracetamol during pregnancy, as well as their child's exposure to the drug during infancy.

Histories of wheezing and any asthma and allergy symptoms and diagnoses in the children were recorded, along with details of environmental exposures and family lifestyles. Between ages 7 and 8, the children had allergy skin and blood tests and lung function tests. Both mothers and children had genetic testing performed.

Professor Shaheen and researchers found evidence suggesting that the risk of childhood asthma associated with prenatal paracetamol exposure depended on which variants of various antioxidant genes were present in the mother. In contrast, interactions between infant paracetamol use and similar gene variants in the child were not seen.

Our latest findings add further weight to the evidence implicating prenatal paracetamol exposure in the development of childhood asthma. However, ultimately a cause and effect relationship can only be confirmed through randomised clinical trials, said Shaheen.

The scientists concluded that maternal antioxidant gene polymorphisms may modify the relation between prenatal paracetamol exposure and childhood asthma, strengthening evidence for a causal association.

In contrast, relations between infant paracetamol use and asthma and atopy were not modified by child genotype and may be confounded by pre-existing wheeze or allergy.